Sanofi Consumer Healthcare Inc Stock Price Today (NSE: SANOFICONR)
Fundamental Score
Sanofi Consumer Healthcare Inc Share Price Live NSE/BSE & Institutional Fundamental Analysis
Sanofi Consumer Healthcare Inc share price today is ₹4179.80, up +0.00% on NSE/BSE as of 17 February 2026. Sanofi Consumer Healthcare Inc (SANOFICONR) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹10.65K (Cr). The 52-week high for SANOFICONR share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 49.57x, SANOFICONR is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 83.81% and a debt-to-equity ratio of 0.11.
Sanofi Consumer Healthcare Inc Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Sanofi Consumer Healthcare Inc Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Sanofi Consumer Healthcare Inc Share Price
The pharmaceutical industry, often perceived as defensive, is currently experiencing a period of dynamic growth fueled by an aging global population and increasing healthcare spending. This analysis delves into the financial standing of Sanofi Consumer Healthcare Inc, focusing on its current market valuation and profitability. The current Sanofi Consumer Healthcare Inc share price stands at ₹4252.100098, accompanied by a Price-to-Earnings (PE) ratio of 49.57.
The PE ratio of 49.57 suggests a relatively high market expectation for future earnings growth. To gauge the reasonableness of this valuation, it's important to consider Sanofi Consumer Healthcare Inc's performance relative to its peers. While a direct comparison requires further in-depth analysis, observing competitors like Mankind Pharma Ltd gives us context.
Mankind Pharma Ltd Investigating the management quality of both companies can reveal qualitative factors potentially justifying valuation differences. A deeper dive is warranted to fully understand the sustainability of Sanofi's current valuation.A particularly striking metric is the Return on Capital Employed (ROCE) of 111.44%. This figure indicates exceptional efficiency in generating profits from invested capital. Such a high ROCE potentially strengthens Sanofi Consumer Healthcare Inc's economic moat, as it demonstrates a significant competitive advantage in deploying capital and achieving superior returns. This impressive efficiency may give Sanofi greater pricing power or the ability to invest in innovation, furthering its market position. However, it is crucial to assess the sustainability of this high ROCE; can it be maintained over the long term, or is it influenced by transient factors?
This analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, providing a detailed perspective on Sanofi Consumer Healthcare Inc's financial health. It is important to remember that this analysis is purely observational and does not constitute investment advice. Further due diligence is recommended before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sanofi Consumer Healthcare Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SANOFICONR across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (83.81%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (111.44%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (37.13%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (46.28%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (153.05x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (71.27%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Premium Valuation Risk (P/E: 49.57x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Sanofi Consumer Healthcare Inc Financial Statements
Comprehensive financial data for Sanofi Consumer Healthcare Inc including income statement, balance sheet and cash flow
About SANOFICONR (Sanofi Consumer Healthcare Inc)
Sanofi Consumer Healthcare Inc (SANOFICONR) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹10.65K (Cr). Sanofi Consumer Healthcare Inc has delivered a Return on Equity (ROE) of 83.81% and a ROCE of 111.44%. The debt-to-equity ratio stands at 0.11, reflecting the company's capital structure. Investors tracking SANOFICONR share price can monitor key metrics including P/E ratio, promoter holding of 71.27%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
SANOFICONR Share Price: Frequently Asked Questions
What is the current share price of Sanofi Consumer Healthcare Inc (SANOFICONR)?
As of 17 Feb 2026, 10:21 am IST, Sanofi Consumer Healthcare Inc share price is ₹4179.80. The SANOFICONR stock has a market capitalisation of ₹10.65K (Cr) on NSE/BSE.
Is SANOFICONR share price Overvalued or Undervalued?
SANOFICONR share price is currently trading at a P/E ratio of 49.57x, compared to the industry average of 31.77x. Based on this relative valuation, the Sanofi Consumer Healthcare Inc stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of SANOFICONR share price?
The 52-week high of SANOFICONR share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Sanofi Consumer Healthcare Inc share price?
Key factors influencing SANOFICONR share price include quarterly earnings growth (Sales Growth: 46.28%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Sanofi Consumer Healthcare Inc a good stock for long-term investment?
Sanofi Consumer Healthcare Inc shows a 5-year Profit Growth of N/A% and an ROE of 83.81%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.11 before investing in SANOFICONR shares.
How does Sanofi Consumer Healthcare Inc compare with its industry peers?
Sanofi Consumer Healthcare Inc competes with major peers in the Pharmaceuticals. Investors should compare SANOFICONR share price P/E of 49.57x and ROE of 83.81% against the industry averages to determine competitive standing.
What is the P/E ratio of SANOFICONR and what does it mean?
SANOFICONR share price has a P/E ratio of 49.57x compared to the industry average of 31.77x. Investors pay ₹50 for every ₹1 of annual earnings.
How is SANOFICONR performing according to Bull Run's analysis?
SANOFICONR has a Bull Run fundamental score of 51.2/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SANOFICONR belong to?
SANOFICONR operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sanofi Consumer Healthcare Inc share price.
What is Return on Equity (ROE) and why is it important for SANOFICONR?
SANOFICONR has an ROE of 83.81%, which indicates excellent management efficiency. ROE measures how efficiently Sanofi Consumer Healthcare Inc generates profits from shareholders capital.
How is SANOFICONR debt-to-equity ratio and what does it indicate?
SANOFICONR has a debt-to-equity ratio of 0.11, which indicates conservative financing with low financial risk.
What is SANOFICONR dividend yield and is it a good dividend stock?
SANOFICONR offers a dividend yield of 1.19%, meaning you receive ₹1.19 annual dividend for every ₹100 invested in Sanofi Consumer Healthcare Inc shares.
How has SANOFICONR share price grown over the past 5 years?
SANOFICONR has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in SANOFICONR and why does it matter?
Promoters hold 71.27% of SANOFICONR shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Sanofi Consumer Healthcare Inc.
What is SANOFICONR market capitalisation category?
SANOFICONR has a market capitalisation of ₹10652 crores, placing it in the Mid-cap category.
How volatile is SANOFICONR stock?
SANOFICONR has a beta of N/A. A beta > 1 suggests the Sanofi Consumer Healthcare Inc stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SANOFICONR operating profit margin trend?
SANOFICONR has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is SANOFICONR quarterly performance?
Recent quarterly performance shows Sanofi Consumer Healthcare Inc YoY Sales Growth of 46.28% and YoY Profit Growth of 37.13%.
What is the institutional holding pattern in SANOFICONR?
SANOFICONR has FII holding of 2.94% and DII holding of 17.21%. Significant institutional holding often suggests professional confidence in the Sanofi Consumer Healthcare Inc stock.